{"id":"W2486896794","doi":"10.1182/blood.v124.21.3075.3075","title":"Safe and Effective Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) and Low Baseline Platelet Counts with Belinostat","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Peripheral T-cell lymphoma; Clinical endpoint; Vincristine; Clinical trial; Prednisone; Gastroenterology; Cyclophosphamide; CHOP; Lymphoma; Refractory (planetary science); Oncology; Adverse effect; Surgery; Chemotherapy; Immunology; T cell; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003522653,0.000160699,0.0005395755,0.0002082783,0.0001993895,0.0003229955,0.0001773252,0.0002328726,0.001221782],"category_scores_gemma":[0.0008067387,0.00009882377,0.0002969588,0.0001535685,0.0001523536,0.0003416598,0.0002918663,0.0005003547,0.0002865526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003414575,"about_ca_system_score_gemma":0.0005306673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002659827,"about_ca_topic_score_gemma":0.00109868,"domain_scores_codex":[0.9998251,0.00006341688,0.00001916397,0.00002537717,0.00003921072,0.0000277501],"domain_scores_gemma":[0.9997321,0.00005188945,0.00008339111,0.00001897685,0.00002335172,0.00009020763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03257294,0.003193304,0.07253221,0.0006447456,0.0004115743,0.001683855,0.0002259734,0.0009794311,0.01661294,0.0008897854,0.01251299,0.8577402],"study_design_scores_gemma":[0.05635991,0.08434804,0.7436079,0.0006536348,0.001474773,0.01453171,0.0005144333,0.008179842,0.01338435,0.0038762,0.07297041,0.00009870791],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9649052,0.01922168,0.003360996,0.001911118,0.0001823232,0.0004554317,0.0007027955,0.0002330889,0.009027482],"genre_scores_gemma":[0.9949808,0.001600981,0.001232412,0.0007332627,0.0001164888,0.0001283414,0.0005731924,0.000009460688,0.0006250951],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001221782,"threshold_uncertainty_score":0.004087269,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002810827406808201,"score_gpt":0.2040913066082023,"score_spread":0.2012804792013941,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}